Transplant Diagnostics Market worth $5.5 billion by 2025

1
Request Sample
2
Transplant Diagnostics Market worth 5.5 billion
by 2025
MARKET OPPORTUNITY OVER NEXT 5 YEARS
TWO OF THE KEY DRIVERS OF THE MARKET WILL BE
KEY MARKET PLAYERS
CAGR of 7.2
2020 2025

• Bio-Rad Laboratories, Inc. (US)
• F. Hoffman-La Roche Ltd. (Switzerland)
• QIAGEN N.V.

CAGR

• High incidence of cancer and other target diseases

North America dominates the Transplant
Diagnostics market
Market Segmentation by Equipment category

• Based on product, the reagents consumables
  segment held the largest share of the market
• Based on technology, the molecular assays segment
  is expected to witness the highest growth during
  the forecast period.

The demand for transplant diagnostic products is
expected to grow mainly due to factors such as
technological advancements, the growing number of
diagnostic centers hospitals, increased
applications in patient profiling, and rising
public-private investments to support product
development.

3
Transplant Diagnostics Market worth 5.5 billion
by 2025
The report "Transplant Diagnostics Market by
Technology (PCR, NGS, Sanger Sequencing), Product
(Instrument, Reagent, Software), Application
(HLA, Blood Profile, Pathogen Detection), Type
(Heart, Kidney, Liver, Bone Marrow), End User
(Hospital) - Global Forecast to 2025" The
transplant diagnostics market is expected to
reach USD 5.5 billion by 2025 from USD 3.6
billion in 2019, at a CAGR of 7.2. Browse 153
market data Tables and 45 Figures spread
through 227 Pages and in-depth TOC on "Transplant
Diagnostics Market by Technology (PCR, NGS,
Sanger Sequencing), Product (Instrument, Reagent,
Software), Application (HLA, Blood Profile,
Pathogen Detection), Type (Heart, Kidney, Liver,
Bone Marrow), End User (Hospital) - Global
Forecast to 2025"View detailed Table of Content
here - https//www.marketsandmarkets.com/Market-Re
ports/global-transplant-diagnostics-market-2531061
.html
4
Transplant Diagnostics Market worth 5.5 billion
by 2025
The demand for transplant diagnostic products is
expected to grow mainly due to factors such as
technological advancements, the growing number of
diagnostic centers hospitals, increased
applications in patient profiling, and rising
public-private investments to support product
development. These factors have prompted market
players to improve and strengthen their current
manufacturing and distribution capabilities-especi
ally in emerging markets, which are expected to
witness the highest growth. Based on product,
the reagents consumables segment held the
largest share of the market in 2019. On the basis
of product, the transplant diagnostics market is
segmented into reagents consumables,
instruments, and software services. The
reagents consumables segment held the largest
share of the global transplant diagnostics market
in 2019. Factors such as the increasing patient
emphasis on effective and early patient profiling
during organ transplantation and the growing
adoption of transplant diagnostic techniques in
related research studies are driving the growth
of this segment.
5
Transplant Diagnostics Market worth 5.5 billion
by 2025
Based on technology, the molecular assays segment
is expected to witness the highest growth during
the forecast period. On the basis of technology,
the transplant diagnostics market is segmented
into molecular assay and non-molecular assay
technology. The molecular assay technology
segment is expected to register the highest CAGR
during the forecast period. Factors such as its
varied applications in patient profiling, rising
public-private investments to support product
development, and increasing clinical evidence of
its efficacy are driving the growth of this
segment. Based on the transplant type, the solid
organ transplantation segment accounted for the
largest share of this market in 2019. On the
basis of transplant type, the transplant
diagnostics market is categorized into solid
organ, stem cell, and soft tissue
transplantation. Solid organ transplantation
accounted for the largest share of the transplant
diagnostics market in 2019. Supportive government
regulations to increase organ donations across
major healthcare markets, the rising number of
chronic diseases/disorders leading to
transplantation, and ongoing technological
advancements in the field of transplant
diagnostics are the key factors supporting the
growth of the market for solid organ
transplantation.
6
Transplant Diagnostics Market worth 5.5 billion
by 2025
North America accounted for the largest share of
the transplant diagnostics market in 2019 North
America accounted for the largest share of the
transplant diagnostics market in 2019, followed
by Europe. This can primarily be attributed to
the continuous commercialization of innovative
transplant diagnostic products coupled with
ongoing advancements in the field of genomics and
proteomics, recent discovery genetic biomarkers
their clinical role in immunoassay testing, and
the increasing prevalence of chronic and
communicable diseases. Some of the prominent
players in the transplant diagnostics market are
Bio-Rad Laboratories, Inc. (US), F. Hoffman-La
Roche Ltd. (Switzerland), QIAGEN N.V.
(Netherlands), Thermo Fisher Scientific Inc.
(US), and bioMérieux S.A. (France). Others are
Immucor, Inc. (US), Illumina, Inc. (US), Luminex
Corporation (US), CareDx (US), Becton, Dickinson
and Company (US), Hologic (US), and GenDx
(Netherlands). Dont miss out on business
opportunities in Transplant Diagnostics Market.
Speak to our analyst and gain crucial industry
insights that will help your business grow.
7
About MarketsandMarkets
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 7500 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues
decisions. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high
growth markets following the "Growth Engagement
Model GEM". The GEM aims at proactive
collaboration with the clients to identify new
opportunities, identify most important customers,
write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both
the company and its competitors.
MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across
leaders, emerging companies, innovators,
strategic players) annually in high growth
emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.
8
Contact
Mr. Aashish Mehra MarketsandMarkets INC. 630
Dundee Road Suite 430 Northbrook, IL 60062 USA
1-888-600-6441 sales_at_marketsandmarkets.com